Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

CNS 1

Conditions

Breast Neoplasms 30Central Nervous System Neoplasms 18Rectal Neoplasms 15Colorectal Neoplasms 15Lung Neoplasms 13Colonic Neoplasms 11Carcinoma, Non-Small-Cell Lung 11Stomach Neoplasms 9Pancreatic Neoplasms 9Glioblastoma 9Gliosarcoma 7Neoplasm Metastasis 6Esophageal Neoplasms 6Brain Neoplasms 6Adenocarcinoma Of Esophagus 6Carcinoma, Intraductal, Noninfiltrating 5Breast Neoplasms, Male 5Breast Carcinoma In Situ 5Squamous Cell Carcinoma of Head and Neck 4Sarcoma 4Mesothelioma, Malignant 4Kidney Neoplasms 4Head and Neck Neoplasms 4Carcinoma, Renal Cell 4Astrocytoma 4Uterine Cervical Neoplasms 3Urinary Bladder Neoplasms 3Solitary Fibrous Tumor, Pleural 3Prostatic Neoplasms 3Ovarian Neoplasms 3

Interventions

antineoplaston AS 2-1 4antineoplaston A10 4Cyclophosphamide 4Cisplatin 4Temozolomide 3Radiotherapy 3dactolisib 2Vincristine 2Filgrastim 2Everolimus 2Etoposide 2Bevacizumab 2spartalizumab 1sargramostim 1pasireotide 1ganitumab 1gallium Ga 68 dotatate 1fosbretabulin 1cixutumumab 1belzutifan 1aldesleukin 1Topotecan 1Thiotepa 1TH 302 1Sunitinib 1Standard of Care 1Pregabalin 1Peripheral Blood Stem Cell Transplantation 1Pemetrexed 1Paclitaxel 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 2 × Neuroectodermal Tumors, Primitive × Chemotherapy, Adjuvant × Clear all
NCT00006258 2013-07-18

Combination Chemotherapy Followed by Radiation Therapy in Treating Patients With Medulloblastoma, Supratentorial Primitive Neuroectodermal Tumor, or Ependymoma

National Cancer Institute (NCI)

Phase 2 Completed
CNS

Ependymoma, Medulloblastoma, Central Nervous System Neoplasms, Neuroectodermal Tumors, Primitive

Data powered by HemOnc (CC BY 4.0) Colophon âš¡